As over 80% of PCa shows dependence on androgens, most treatments are directed towards inhibiting the AR activity either by using antiandrogens, lowering the secretion of testosterone by surgical castration, or by using luteinizing hormone-releasing hormone (LHRH) agonists and antagonists (122, 123). This evidence concerns the gene AR and posterior cortical atrophy.